225 related articles for article (PubMed ID: 20920340)
21. Immunohistochemical analysis of tumor polyamines discriminates high-risk patients undergoing nephrectomy for renal cell carcinoma.
Rioux-Leclercq N; Delcros JG; Bansard JY; Epstein JI; Patard JJ; Lobel B; Guillé F; Jouan F; Bellaud P; Moulinoux JP
Hum Pathol; 2004 Oct; 35(10):1279-84. PubMed ID: 15492997
[TBL] [Abstract][Full Text] [Related]
22. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
23. ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma.
Li C; Li H; Zhang T; Li J; Ma F; Li M; Sui Z; Chang J
Med Sci Monit; 2015 Nov; 21():3380-5. PubMed ID: 26540164
[TBL] [Abstract][Full Text] [Related]
24. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
25. Decoy receptor 3 is a prognostic factor in renal cell cancer.
Macher-Goeppinger S; Aulmann S; Wagener N; Funke B; Tagscherer KE; Haferkamp A; Hohenfellner M; Kim S; Autschbach F; Schirmacher P; Roth W
Neoplasia; 2008 Oct; 10(10):1049-56. PubMed ID: 18813347
[TBL] [Abstract][Full Text] [Related]
26. Expression of molecular markers associated with the mammalian target of rapamycin pathway in nonmetastatic renal cell carcinoma: Effect on prognostic outcomes following radical nephrectomy.
Nishikawa M; Miyake H; Harada K; Fujisawa M
Urol Oncol; 2014 Jan; 32(1):49.e15-21. PubMed ID: 24239474
[TBL] [Abstract][Full Text] [Related]
27. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors in renal cell cancer.
Macher-Goeppinger S; Aulmann S; Tagscherer KE; Wagener N; Haferkamp A; Penzel R; Brauckhoff A; Hohenfellner M; Sykora J; Walczak H; Teh BT; Autschbach F; Herpel E; Schirmacher P; Roth W
Clin Cancer Res; 2009 Jan; 15(2):650-9. PubMed ID: 19147771
[TBL] [Abstract][Full Text] [Related]
29. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
30. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.
Hirata H; Hinoda Y; Shahryari V; Deng G; Nakajima K; Tabatabai ZL; Ishii N; Dahiya R
Cancer Res; 2015 Apr; 75(7):1322-31. PubMed ID: 25600645
[TBL] [Abstract][Full Text] [Related]
31. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of EZH2 exerts antitumorigenic effects in renal cell carcinoma via LATS1.
Hong SH; Hwang HJ; Son DH; Kim ES; Park SY; Yoon YE
FEBS Open Bio; 2023 Apr; 13(4):724-735. PubMed ID: 36808829
[TBL] [Abstract][Full Text] [Related]
33. The enhancer of zeste homolog 2 (EZH2), a potential therapeutic target, is regulated by miR-101 in renal cancer cells.
Sakurai T; Bilim VN; Ugolkov AV; Yuuki K; Tsukigi M; Motoyama T; Tomita Y
Biochem Biophys Res Commun; 2012 Jun; 422(4):607-14. PubMed ID: 22609199
[TBL] [Abstract][Full Text] [Related]
34. High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma.
Haferkamp A; Bedke J; Vetter C; Pritsch M; Wagener N; Buse S; Crnkovic-Mertens I; Hoppe-Seyler K; Macher-Goeppinger S; Hoppe-Seyler F; Autschbach F; Hohenfellner M
BJU Int; 2008 Dec; 102(11):1700-6. PubMed ID: 18990137
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
Cao W; Feng Z; Cui Z; Zhang C; Sun Z; Mao L; Chen W
Cancer; 2012 Jun; 118(11):2858-71. PubMed ID: 21989926
[TBL] [Abstract][Full Text] [Related]
36. Adipophilin as prognostic biomarker in clear cell renal cell carcinoma.
Tolkach Y; Lüders C; Meller S; Jung K; Stephan C; Kristiansen G
Oncotarget; 2017 Apr; 8(17):28672-28682. PubMed ID: 28404922
[TBL] [Abstract][Full Text] [Related]
37. High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer.
Reijm EA; Timmermans AM; Look MP; Meijer-van Gelder ME; Stobbe CK; van Deurzen CHM; Martens JWM; Sleijfer S; Foekens JA; Berns PMJJ; Jansen MPHM
Ann Oncol; 2014 Nov; 25(11):2185-2190. PubMed ID: 25193989
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of CXCR4 expression in patients with clear cell renal cell carcinoma.
Li G; Badin G; Zhao A; Gentil-Perret A; Tostain J; Péoc'h M; Gigante M
Histol Histopathol; 2013 Sep; 28(9):1217-22. PubMed ID: 23609324
[TBL] [Abstract][Full Text] [Related]
39. Opposite prognostic roles of HIF1α and HIF2α expressions in bone metastatic clear cell renal cell cancer.
Szendrői A; Szász AM; Kardos M; Tőkés AM; Idan R; Szűcs M; Kulka J; Nyirády P; Szendrői M; Szállási Z; Győrffy B; Tímár J
Oncotarget; 2016 Jul; 7(27):42086-42098. PubMed ID: 27244898
[TBL] [Abstract][Full Text] [Related]
40. Impact of sarcomatoid differentiation and rhabdoid differentiation on prognosis for renal cell carcinoma with vena caval tumour thrombus treated surgically.
Yang B; Xia H; Xu C; Lu M; Zhang S; Wang G; Ma L
BMC Urol; 2020 Feb; 20(1):14. PubMed ID: 32070319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
